62% of patients were progression-free at 18 months post-transplantation
A closer look at a promising therapy
Cleveland Clinic study finds regimen helps improve outcomes
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy